JeremieCalaisMDPhD

Summary

• Assistant Professor at the Ahmanson Translational Theranostics Division of the Department of Molecular and Medical Pharmacology. Dr. Calais received his MD degree from the University of Paris-Diderot in 2010. He subsequently trained in nuclear medicine and cancer imaging at the Henri Becquerel Cancer Center of the University of Rouen and was board certified by the French Society of Nuclear Medicine in 2014. His work focuses on improving the outcomes of cancer patients by translating and applying novel diagnostic and therapeutic approaches. He uses PET/CT imaging for cancer phenotyping, radiation therapy planning and therapy response assessment. He leads the clinical research program of Nuclear Medicine and Theranostics at UCLA that combines radionuclide therapy and imaging.

New Scan Finds Prostate Cancer Cells Hiding in the Body
The test seems likely to improve the diagnosis and treatment of a disease that kills 33,000 American men each year. After doctors found cancer in Dr. Mark Sambe